Bots, editor, reviewer, Administrators
13,951
edits
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==June 2025== | ==June 2025== | ||
; [[STEP-HFpEF]]: New summary #519: Semaglutide in HFpEF+obesity but no DM | |||
; [[PACIFIC]]: New summary #518: Durvalumab vs. placebo as consolidation in NSCLC | ; [[PACIFIC]]: New summary #518: Durvalumab vs. placebo as consolidation in NSCLC | ||